Investigating the long-term health effects of obesity treatments on women
Official title: MOnitoring NUtritional COnsequences of Obesity Treatment on Women's Health and Transgenerational Effects for Healthier Future Generations: a Multicentre Prospective Observational Cohort Study
Run by Wageningen University and Research · NCT06945016 · Data updated 2026-11-12
This study is trying to see how different obesity treatments affect women's health over time, including their nutrition, bones, muscles, and pregnancy outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | Women only |
| Enrollment | 1150 (estimated) |
| Sponsor | Wageningen University and Research Academic / other |
| Locations | 1 site (Elst, Gelderland) |
| Status | Recruiting |
| Started | January 28, 2025 |
| Main results expected | January 28, 2040 |
| Study ends | January 28, 2040 |
| Registry record updated | July 10, 2025 |
| Trial ID | NCT06945016 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18-55 with a BMI of 30 kg/m2 or higher who are approved for either surgical or pharmacological obesity treatment.
✕Probably not a fit
Patients who are male, under 18 or over 55 years of age, or have a BMI below 30 kg/m2 will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the long-term impacts of obesity treatments on women's health, focusing on nutritional intake, nutritional status, musculoskeletal health, and reproductive health. Participants, aged 18-55 and approved for obesity treatment, will provide data through questionnaires, blood, urine, and feces samples, and undergo body composition and muscle strength measurements over a period of up to 10 years. The study also includes an integrated birth cohort to assess pregnancy outcomes and child development in women who become pregnant during the follow-up.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into how obesity treatments affect women's health and inform better care strategies.
How similar studies have gone: While there have been studies on obesity treatments, this specific long-term observational approach focusing on women's health outcomes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
General Inclusion Criteria: * Female sex at birth * Aged 18-55 years of age * Living with obesity (BMI ≥ 30 kg/m2) * Approved for obesity treatment in one of the participating hospitals: * Undergoing primary bariatric surgery (RYGB, OAGB or SG) * Receiving obesity medication (any type) with a BMI ≥30 kg/m2 under medical supervision. * For those undergoing MRI, DEXA and quantitative ultrasound scan: Willing to be informed about incidental findings of pathology and approving of reporting this to their general physician. Additional inclusion criteria for birth cohort: * Being pregnant * Age 18-45 years of age * Having received prior obesity treatment, either surgical (RYGB, OAGB, SG) or pharmacological for at least 4 months under medical supervision (any type). General Exclusion Criteria: * Male sex at birth * Aged \<18 or \>55 years of age * BMI \<30 kg/m2 * Not able to read and/or write in Dutch * Undergoing a revisional or secondary bariatric procedure (excluding previous gastric banding) * Malnutrition due to other chronic condition, specifically malignancy, substance abuse * (mental) condition that makes it impossible to fill out a questionnaire correctly. * For those undergoing a DEXA scan: height \>196 cm or weight \>160 kg * For those undergoing a MRI scan: having a contra-indication to MRI scanning including (but not limited to) pacemakers and defibrillators, intraorbital or intraocular metallic fragments, ferromagnetic implans or claustrophobia. Additional exclusion criteria birth cohort: * Aged \<18 or \>45 years of age * \>25 weeks of gestation * Multiple pregnancy * Reversal of the bariatric procedure
Where it's running
-
Rijnstate Elst, Vitalys
Elst, Gelderland, Netherlands Recruiting
Study contacts
- Principal investigator: Agnes Berendsen, PhD — Wageningen University and Research
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving alcohol and substance use care during the reproductive years
This project will test whether offering SBIRT (screening, brief intervention, and referral to treatment) in sexual and reproductive health clinics helps adults who screen positive for risky alcohol or drug use reduce substance use and improve mental, reproductive, and overall health.
-
Integrated digital e-clinic for mental health and reproductive health for women and adolescent girls in Jordan
This project tests a digital e-clinic to provide mental health, psychosocial support, and reproductive health information to women and adolescent girls in Jordan, including Syrian refugees.
-
Collagen Supplements After Sleeve Gastrectomy
This observational study looks to see if taking collagen-containing supplements after sleeve gastrectomy affects muscle mass, body composition, and body image in adults who had bariatric surgery.
-
Geranylgeraniol doses to improve muscle strength, body composition, and aerobic fitness
This project will test whether taking daily geranylgeraniol (150 mg or 300 mg) improves muscle strength, lean body mass, and aerobic fitness in healthy, physically active adults aged 30–60.
-
Electrical muscle stimulation plus resistance training for trained weightlifters
This study will test whether adding electrical muscle stimulation (EMS) to regular resistance training helps trained male weightlifters gain more muscle, strength, power, and improved body composition over eight weeks.
-
Daily multivitamin/mineral supplements to improve metabolic, muscle, and mental health in midlife Asian women
This trial will test whether taking a daily multivitamin and mineral supplement for 12 months improves metabolism, mood, and muscle health in Asian women aged 40–60.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.